OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Pharmaceutical Investigation is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Microneedle for transdermal drug delivery: current trends and fabrication	151
Recent advances of nanocellulose in drug delivery systems	71
Characterization studies of novel series of cobalt (II), nickel (II) and copper (II) complexes: DNA binding and antibacterial activity	48
Nanomedicine-based commercial formulations: current developments and future prospects	47
Physical properties of nanoparticles do matter	43
Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors	37
Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research	36
Cellulose and its derivatives for application in 3D printing of pharmaceuticals	30
Fabrication of aerosol-based nanoparticles and their applications in biomedical fields	30
Smart pH-responsive nanomedicines for disease therapy	30
Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects	29
Development of clindamycin-loaded alginate/pectin/hyaluronic acid composite hydrogel film for the treatment of MRSA-infected wounds	28
Recent trends of self-emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs	28
Intestinal membrane transporter-mediated approaches to improve oral drug delivery	26
Recent progress in cancer immunotherapy approaches based on nanoparticle delivery devices	26
Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches	26
Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals	24
Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy	22
Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity	20
Lipid-based nanoparticles for photosensitive drug delivery systems	19
Pharmaceutical application and development of fixed-dose combination: dosage form review	18
Response surface optimization of self nano-emulsifying drug delivery system of rosuvastatin calcium for hepatocellular carcinoma	17
Development of oral aprepitant-loaded chitosan–polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation	17
Proliposome powder or tablets for generating inhalable liposomes using a medical nebulizer	17
Selenium nanostructure: Progress towards green synthesis and functionalization for biomedicine	16

Recent advances in nano/microparticle-based oral vaccines	16
Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cancer	15
Effects of lipid nanoparticles on physicochemical properties, cellular uptake, and lymphatic uptake of 6-methoxflavone	15
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals	14
Development of topical natural based film forming system loaded propolis from stingless bees for wound healing application	14
Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells	14
Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease	14
Exemestane encapsulated copolymers L121/F127/GL44 based mixed micelles: solubility enhancement and in vitro cytotoxicity evaluation using MCF-7 breast cancer cells	14
Microemulsion as a promising carrier for nose to brain delivery: journey since last decade	13
Tumor spheroid-based microtumor models for preclinical evaluation of anticancer nanomedicines	13
Micronization of a poorly water-soluble drug, fenofibrate, via supercritical-fluid-assisted spray-drying	13
A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches	12
A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor	12
pH-sensitive beads containing curcumin loaded nanostructured lipid carriers for a colon targeted oral delivery system	12
A quality by design approach in oral extended release drug delivery systems: where we are and where we are going?	12
Three-Dimensional Printing for Oral Pharmaceutical Dosage Forms	12
Anti-inflammatory effects of a topical emulsion containing Helianthus annuus oil, glycerin, and vitamin B3 in mice	12
Development of a zero-order kinetics drug release floating tablet with anti–flip-up design fabricated by 3D-printing technique	12
Progress and recent trends in photodynamic therapy with nanoparticles	12
Quality by Design (QbD) application for the pharmaceutical development process	12
Ultra deformable vesicles for boosting transdermal delivery of 2-arylpropionic acid class drug for management of musculoskeletal pain	12
Recent studies on modulating hyaluronic acid-based hydrogels for controlled drug delivery	12
Ameliorative potential of Sterculia tragacantha aqueous extract on renal gene expression and biochemical parameters in streptozotocin-induced diabetic rats	11
Current perspectives of artificial oxygen carriers as red blood cell substitutes: a review of old to cutting-edge technologies using in vitro and in vivo assessments	11
Thermosensitive nasal in situ gelling systems of rufinamide formulated using modified tamarind seed xyloglucan for direct nose-to-brain delivery: design, physical characterization, and in vivo evaluat	11
Microneedle systems for delivering nucleic acid drugs	11
Simple determination and quantification of tofacitinib, a JAK inhibitor, in rat plasma, urine and tissue homogenates by HPLC and its application to a pharmacokinetic study	10
Potential therapeutic and pharmacological strategies for SARS-CoV2	10
Population pharmacokinetic analysis of lornoxicam in healthy Korean males considering creatinine clearance and CYP2C9 genetic polymorphism	10
Graphene-based nanomaterial system: a boon in the era of smart nanocarriers	9
Statistical design of experiment-based formulation development and optimization of 3D printed oral controlled release drug delivery with multi target product profile	9
Distribution of “molybdenum disulfide/cobalt ferrite” nanocomposite in animal model of breast cancer, following injection via differential infusion flow rates	8
Alginate-coated chitosan nanoparticles protect protein drugs from acid degradation in gastric media	8
High frequency ultrasound mediated transdermal delivery of ondansetron hydrochloride employing bilosomal gel systems: ex-vivo and in-vivo characterization studies	8
Evaluating the efficacy of different curcumin polymorphs in transdermal drug delivery	8
5-[(3-Carboxy-4-hydroxyphenyl)diazenyl] nicotinic acid, an azo-linked mesalazine-nicotinic acid conjugate, is a colon-targeted mutual prodrug against dextran sulfate sodium-induced colitis in mice	8
Dose-independent pharmacokinetics of loganin in rats: effect of intestinal first-pass metabolism on bioavailability	8
Erythromycin dermal delivery by MoS2 nanoflakes	8
Ophthalmic dosage forms for drug delivery to posterior segment	8
Application of mechanism-based modeling to predict drug quality during the pharmaceutical unit operations of granulation and compression: a review	8
Bacteriophages: cancer diagnosis, treatment, and future prospects	8
Quality by design approach to the development of transdermal patch systems and regulatory perspective	7
In vivo evaluation of biodistribution and toxicity of pH-responsive strontium nanoparticles for gene delivery	7
Surface modification strategies for high-dose dry powder inhalers	7
Advanced technology using supercritical fluid for particle production in pharmaceutical continuous manufacturing	6
Oral cavity: An open horizon for nanopharmaceuticals	6
Effects of 1α,25-dihydroxyvitamin D3 on the pharmacokinetics and biodistribution of ergothioneine, an endogenous organic cation/carnitine transporter 1 substrate, in rats	6
Pharmacokinetics and hypoglycemic effect of gliclazide loaded in Isabgol husk mucilage microparticles	6
Formulation of sustained-release orodispersible film containing drug–resin complexes of donepezil hydrochloride	6
Bilayer tablets with sustained-release metformin and immediate-release sitagliptin: preparation and in vitro/in vivo evaluation	6

Nanomedicine approaches for medulloblastoma therapy	6
Design and synthesis of potential nano-carrier for delivery of diphencyprone to hair follicle	6
Orodispersible film incorporating nanoparticulate loratadine for an enhanced oral bioavailability	6
Treatment of Wilms’ nephroblastoma cancer cells via EGFR targeting of dactinomycin loaded DNA-nanowires	6
Regulation of drug transporters by microRNA and implications in disease treatment	5
An overview of chondrosarcoma with a focus on nanoscale therapeutics	5
Dissolving microneedle arrays that compensated for skin water loss due to microporation	5
Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients	5
Peptide permeation enhancers for improving oral bioavailability of macromolecules	5
In vitro and in vivo evaluations of a 3-month sustained-release microsphere depot formulation of leuprolide acetate	5
Tumor extracellular vesicles carrying antitumor (KLAKLAK)2 peptide and tumor-specific antigens for improved tumor therapy	5
Design of experiment (DoE)-based formulation design of bepotastine sustained-release tablet and in vitro-in vivo pharmacokinetic correlation	5
Intratympanic drug delivery systems to treat inner ear impairments	4
Tableting process-induced solid-state polymorphic transition	4
Mitigating off-target distribution and enhancing cytotoxicity in breast cancer cells with alpha-ketoglutaric acid-modified Fe/Mg-CA nanoparticles	4
Physicochemical analysis techniques specialized in surface characterization of inhalable dry powders	4
Tumor-originated pH-responsive nanovaccine mixture to treat heterogeneous tumors	4
Antimicrobial strategies for topical biofilm-based wound infections: past, present, and future	4
Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tablets	4
Effect of gastric residence time on the oral absorption of rebamipide sustained-release tablets in beagle dogs	4
Establishment of a fexofenadine population pharmacokinetic (PK)–pharmacodynamic (PD) model and exploration of dosing regimens through simulation	4
An economically advantageous amorphous solid dispersion of the fixed combination of lopinavir and ritonavir	4